发布求助
文献互助 智能选刊 最新文献

Drug and Therapeutics Bulletin最新文献

筛选
英文 中文
Cytisinicline for vaping cessation. 戒烟用Cytisinicline。
Drug and Therapeutics Bulletin Pub Date : 2025-04-28 DOI: 10.1136/dtb.2025.000006
{"title":"Cytisinicline for vaping cessation.","authors":"","doi":"10.1136/dtb.2025.000006","DOIUrl":"10.1136/dtb.2025.000006","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"68-69"},"PeriodicalIF":0.0,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical management of ADHD in adults: part 1. 成人ADHD的医疗管理：第1部分。
Drug and Therapeutics Bulletin Pub Date : 2025-04-28 DOI: 10.1136/dtb.2024.000019
Laurence Leaver
{"title":"Medical management of ADHD in adults: part 1.","authors":"Laurence Leaver","doi":"10.1136/dtb.2024.000019","DOIUrl":"https://doi.org/10.1136/dtb.2024.000019","url":null,"abstract":"<p><p>Attention deficit hyperactivity disorder (ADHD) in adults is common, impairing and often unrecognised. Comorbidity is very common and may compound the impact of ADHD. It is important that a diagnosis of ADHD is made following a high-quality assessment. Symptoms and social outcomes can be improved by treatment, particularly medication. Non-pharmacological treatment may be more effective in those who are also on medication, and psychoeducation and environmental modifications are also important. Stimulants such as methylphenidate and lisdexamfetamine are recommended first choice medications. The choice of drug can be tailored to patients' circumstances, especially intended duration of action, then titrated week by week, according to response.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"63 5","pages":"74-80"},"PeriodicalIF":0.0,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent updates from BNF (BNF 89). BNF （BNF 89）的最新更新。
Drug and Therapeutics Bulletin Pub Date : 2025-04-28 DOI: 10.1136/dtb.2025.000012
{"title":"Recent updates from <i>BNF</i> (<i>BNF 89</i>).","authors":"","doi":"10.1136/dtb.2025.000012","DOIUrl":"10.1136/dtb.2025.000012","url":null,"abstract":"<p><p>The BNF is jointly published by the Royal Pharmaceutical Society and BMJ. BNF is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some recent key changes that have been made to BNF content.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"70-73"},"PeriodicalIF":0.0,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143729301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polypill primary prevention: panacea or problematic polypharmacy? 复方药物一级预防：灵丹妙药还是有问题的复方药物？
Drug and Therapeutics Bulletin Pub Date : 2025-04-28 DOI: 10.1136/dtb.2025.000013
David Phizackerley
{"title":"Polypill primary prevention: panacea or problematic polypharmacy?","authors":"David Phizackerley","doi":"10.1136/dtb.2025.000013","DOIUrl":"https://doi.org/10.1136/dtb.2025.000013","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"63 5","pages":"66-67"},"PeriodicalIF":0.0,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144062804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted-release budesonide for patients with IgA nephropathy. 靶向释放布地奈德治疗IgA肾病。
Drug and Therapeutics Bulletin Pub Date : 2025-04-15 DOI: 10.1136/dtb.2024.000071
Isaac Chung, Teck K Khong
{"title":"Targeted-release budesonide for patients with IgA nephropathy.","authors":"Isaac Chung, Teck K Khong","doi":"10.1136/dtb.2024.000071","DOIUrl":"https://doi.org/10.1136/dtb.2024.000071","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143997358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initiating renin-angiotensin system inhibitors in chronic kidney disease. 启动肾素-血管紧张素系统抑制剂治疗慢性肾脏疾病。
Drug and Therapeutics Bulletin Pub Date : 2025-04-02 DOI: 10.1136/dtb.2023.000052
Anna Katharina Forbes, Hugh Gallagher
{"title":"Initiating renin-angiotensin system inhibitors in chronic kidney disease.","authors":"Anna Katharina Forbes, Hugh Gallagher","doi":"10.1136/dtb.2023.000052","DOIUrl":"10.1136/dtb.2023.000052","url":null,"abstract":"<p><p>Chronic kidney disease (CKD) is a heterogeneous group of disorders characterised by abnormalities in kidney structure or function, present for at least 3 months. Renin-angiotensin system (RAS) inhibitors are established treatments in the management of CKD, reducing the risk of adverse kidney and cardiovascular events. Despite an extensive evidence base and decades of clinical experience, they remain underused, underdosed and frequently discontinued due to concerns about changes in kidney function and hyperkalaemia. In this article, we provide an overview of initiating RAS inhibitors in adults with CKD, highlight current guideline recommendations and offer a practical approach to dealing with the challenges associated with their use.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"63 4","pages":"54-58"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143771649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication errors involving intravenous paracetamol in children. 儿童静脉注射扑热息痛的用药错误。
Drug and Therapeutics Bulletin Pub Date : 2025-04-02 DOI: 10.1136/dtb.2024.000073
{"title":"Medication errors involving intravenous paracetamol in children.","authors":"","doi":"10.1136/dtb.2024.000073","DOIUrl":"10.1136/dtb.2024.000073","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"52"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of feminist empowerment messages to sell tests and treatments. 利用女权主义赋权信息来销售检测和治疗。
Drug and Therapeutics Bulletin Pub Date : 2025-04-02 DOI: 10.1136/dtb.2024.000074
Barbara Mintzes
{"title":"Use of feminist empowerment messages to sell tests and treatments.","authors":"Barbara Mintzes","doi":"10.1136/dtb.2024.000074","DOIUrl":"https://doi.org/10.1136/dtb.2024.000074","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"63 4","pages":"50"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143771653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metformin-associated lactic acidosis: a serious complication of a common drug. 二甲双胍相关乳酸酸中毒：一种常见药物的严重并发症。
Drug and Therapeutics Bulletin Pub Date : 2025-04-02 DOI: 10.1136/dtb.2025.260592rep
Kanika Ajay Malani, Arkadiy Finn
{"title":"Metformin-associated lactic acidosis: a serious complication of a common drug.","authors":"Kanika Ajay Malani, Arkadiy Finn","doi":"10.1136/dtb.2025.260592rep","DOIUrl":"10.1136/dtb.2025.260592rep","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"59-63"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semaglutide and nonarteritic anterior ischaemic optic neuropathy. 西马鲁肽与非动脉性前缺血性视神经病变。
Drug and Therapeutics Bulletin Pub Date : 2025-04-02 DOI: 10.1136/dtb.2025.000002
{"title":"Semaglutide and nonarteritic anterior ischaemic optic neuropathy.","authors":"","doi":"10.1136/dtb.2025.000002","DOIUrl":"10.1136/dtb.2025.000002","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信